Rosetta Genomics Ltd. (USA) Stock Nasdaq
Equities
IL0011026494
Biotechnology & Medical Research
Sales 2015 | 8.27M 11.31M | Sales 2016 | 9.23M 12.63M | Capitalization | 9.22M 12.62M |
---|---|---|---|---|---|
Net income 2015 | -17M -23.26M | Net income 2016 | -16M -21.89M | EV / Sales 2015 | 1.07 x |
Net cash position 2015 | 13.54M 18.53M | Net cash position 2016 | 2.45M 3.35M | EV / Sales 2016 | 0.73 x |
P/E ratio 2015 |
-1.07
x | P/E ratio 2016 |
-0.54
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 12-05-23 |
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 09-12-21 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |